ClinicalTrials.gg
CompletedNCT05861791Updated Jul 15, 2024

Comparison of Patient-controlled Analgesia Regimenfor Postoperative Pain in Patients Undergoing Total Knee Arthroplasty

An interventional study of Fentanyl and ketorolac tromethamine with nefopam hydrochloride in Postoperative Pain, Acute, sponsored by Chung-Ang University Gwangmyeong Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 60 Years to 79 Years. Per ClinicalTrials.gov, last updated 2024-07-15.

Sponsored by Chung-Ang University Gwangmyeong Hospital · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Randomized
Ages
60 Years to 79 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 47 studies testing fentanyl in Pain, Postoperative — 5 open to participants now, 6 under way, none of them phase 3. Fentanyl · Pain, Postoperative.

Enrollment
17th of 47
98 · median 80
Started
2023
with 1 other
No phase
12 of 47
2 open now
Registered
35th of 47
by date

Among the 47 studies testing fentanyl in Pain, Postoperative, this one is the 17th largest by enrollment, is one of 2 that started in 2023, is one of 12 with no phase, and was the 35th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

5 of the 47 studies testing fentanyl in Pain, Postoperative are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

About fentanyl

Fentanyl: first FDA approval 1968 (SUBLIMAZE PRESERVATIVE FREE), first EMA approval 2006. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 60 Years to 79 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 47 studies testing fentanyl in Pain, Postoperative, or all of them as a file.
02

Study summary

Patients who undergoing total knee arthroplasty under spinal analgesia will be recruited and randomly assigned to the following two groups according to the regimen of PCA: (A) opioid group who receive only fentanyl citrate 1200mcg for continuous infusion drug, (B) non-opioid group who receive ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug. All the patients will receive additional fentanyl citrate as bolus injection drug if they need more analgesics postoperatively.

03

Conditions studied

  • Postoperative Pain, Acute

Browse trials for

04

Who can participate

Ages eligible
60 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • I-II
  • undergoing elective total knee arthroplasty under spinal anesthesia

Exclusion criteria

Exclusion Criteria:

  • history of stomack ulceration
  • increased ICP
  • bronchial asthma
  • allergy on aspirin, NSAIDs, Nefopam
  • drug user of antiplatelet or anticoagulant
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
98 participants (actual)

Study arms

  • Experimental
    opioid group

    IV-PCA consisted of fentanyl

    Drug: Fentanyl

  • Active comparator
    non-opioid group

    IV-PCA consisted of ketorolac and nefopam

    Drug: ketorolac tromethamine with nefopam hydrochloride

Interventions

  • opioid group receives only fentanyl citrate 1200mcg for continuous infusion drug

    Also known as: opioid group

  • Drugketorolac tromethamine with nefopam hydrochloride

    Drug pages: Ketorolac TromethamineStudies of Ketorolac TromethamineKetorolac Tromethamine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · NefopamStudies of NefopamNefopam pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    non-opioid group receives ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug

06

What researchers measure

Primary outcomes

  1. postoperative pain score

    evaluated by visual analogue scale

    Time frame: 24 hours after the surgery

07

Study locations

1 site
  • ChungAng University Gwangmyeong Hospital
    Gyeonggi-do, Gwangmyeon-si 14353, Korea, Republic of
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2023 to primary completion in Jul 2024, 17 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 17 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 8, 2023
First posted
May 17, 2023
StartActual
Feb 7, 2023
Primary completionActual
Jul 12, 2024
CompletionActual
Jul 12, 2024
Last update
Jul 15, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05861791
Lead sponsor
Chung-Ang University Gwangmyeong Hospital
Responsible party
Se-Hee Min (Assistant professor, Chung-Ang University Gwangmyeong Hospital) — Principal investigator
First posted
May 17, 2023
Start date
Feb 7, 2023
Primary completion
Jul 12, 2024
Completion
Jul 12, 2024
Last update
Jul 15, 2024

Study contacts

Se-Hee Min
principal investigator · ChungAng University Gwangmyeon Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Fentanyl

Start the discussion